Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human immunodeficiency virus-associated dementia: an evolving disease.

Literature DB >> 12707851

Human immunodeficiency virus-associated dementia: an evolving disease.

Justin C McArthur¹, Norman Haughey, Suzanne Gartner, Kathy Conant, Carlos Pardo, Avi Nath, Ned Sacktor.

Abstract

This article reviews the changing epidemiology of HIV-associated dementia, current concepts of the different patterns of dementia under the influence of highly active antiretroviral therapy, and reviews therapeutic aspects.

Entities: Disease Species

Mesh：

Year: 2003 PMID： 12707851 DOI： 10.1080/13550280390194109

Source DB: PubMed Journal: J Neurovirol ISSN： 1355-0284 Impact factor: 2.643

136 in total

Review 1. Targeting neurotherapeutic agents through the blood-brain barrier.

Authors: William M Pardridge
Journal: Arch Neurol Date: 2002-01

2. PCR detection of HIV proviral DNA in the brain of an asymptomatic HIV-positive patient.

Authors: E Sinclair; F Gray; F Scaravilli
Journal: J Neurol Date: 1992-10 Impact factor: 4.849

3. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry.

Authors: K Takahashi; S L Wesselingh; D E Griffin; J C McArthur; R T Johnson; J D Glass
Journal: Ann Neurol Date: 1996-06 Impact factor: 10.422

4. Variable progression of HIV-associated dementia.

Authors: F H Bouwman; R L Skolasky; D Hes; O A Selnes; J D Glass; T E Nance-Sproson; W Royal; G J Dal Pan; J C McArthur
Journal: Neurology Date: 1998-06 Impact factor: 9.910

5. Prospects for therapy of HIV-associated neurologic diseases.

Authors: N Sacktor; J McArthur
Journal: J Neurovirol Date: 1997-04 Impact factor: 2.643

Review 6. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs.

Authors: R T Schooley
Journal: AIDS Date: 1995-12 Impact factor: 4.177

7. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

Authors: M C Zink; G D Coleman; J L Mankowski; R J Adams; P M Tarwater; K Fox; J E Clements
Journal: J Infect Dis Date: 2001-09-10 Impact factor: 5.226

8. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis.

Authors: M Cherner; E Masliah; R J Ellis; T D Marcotte; D J Moore; I Grant; R K Heaton
Journal: Neurology Date: 2002-11-26 Impact factor: 9.910

9. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death.

Authors: N C Sacktor; H Bacellar; D R Hoover; T E Nance-Sproson; O A Selnes; E N Miller; G J Dal Pan; C Kleeberger; A Brown; A Saah; J C McArthur
Journal: J Neurovirol Date: 1996-12 Impact factor: 2.643

Review 10. Bacterial and fungal brain infections in AIDS.

Authors: C M Marra
Journal: Semin Neurol Date: 1999 Impact factor: 3.420

175 in total

1. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.

Authors: K Robertson; H Jiang; J Kumwenda; K Supparatpinyo; S Evans; T B Campbell; R Price; S Tripathy; N Kumarasamy; A La Rosa; B Santos; M T Silva; S Montano; C Kanyama; S Faesen; R Murphy; C Hall; C M Marra; C Marcus; B Berzins; R Allen; M Housseinipour; F Amod; I Sanne; J Hakim; A Walawander; A Nair
Journal: Clin Infect Dis Date: 2012-06-01 Impact factor: 9.079

Review 2. The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections.

Authors: David F Tate; Rola Khedraki; Daniel McCaffrey; Daniel Branson; Jeffrey Dewey
Journal: Neurotherapeutics Date: 2011-01 Impact factor: 7.620

Review 3. Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors: Gloria Lee; Reina Bendayan
Journal: Pharm Res Date: 2004-08 Impact factor: 4.200

Review 4. The neurology of HIV infection.

Authors: H Manji; R Miller
Journal: J Neurol Neurosurg Psychiatry Date: 2004-03 Impact factor: 10.154

5. Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.

Authors: James T Becker; Melissa Fabrizio; Gustavo Sudre; Anna Haridis; Timothy Ambrose; Howard J Aizenstein; William Eddy; Oscar L Lopez; David A Wolk; Lauri Parkkonen; Anto Bagic
Journal: J Neurosci Methods Date: 2012-03-05 Impact factor: 2.390

Review 6. Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction.

Authors: K Grovit-Ferbas; M E Harris-White
Journal: Immunol Res Date: 2010-12 Impact factor: 2.829

7. Host and virus strain dependence in activation of human macrophages by human immunodeficiency virus type 1.

Authors: Katarzyna Kazmierczak; Mary Jane Potash
Journal: J Neurovirol Date: 2007-10 Impact factor: 2.643

8. Discordant genotypic resistance and HIV-1 genetic diversity from paired plasma and cerebrospinal fluid samples in Chinese settings.

Authors: Lifeng Liu; Yulin Zhang; Feili Wei; Qingxia Zhao; Xicheng Wang; Lin Yuan; Ning Li; Dexi Chen
Journal: J Neurovirol Date: 2013-01-17 Impact factor: 2.643

Review 9. Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors: Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal: Curr HIV Res Date: 2015 Impact factor: 1.581

10. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array.

Authors: Thorsten Nolting; Antje Lindecke; Eleni Koutsilieri; Matthias Maschke; Ingo-W Husstedt; Sieghart Sopper; Olaf Stüve; Hans-Peter Hartung; Gabriele Arendt
Journal: J Neurovirol Date: 2009-09 Impact factor: 2.643